- IV¡¥¾·ÀÁ¹Ö±é
- 1¡¥Importance of Polymer Biocompatibility for Drug Eluting Stent ¡Ê DES¡Ë Outcomes
Josiah N. Wilcox ¡ÊMedtronic CardioVascular, USA¡Ë
ºÂĹ¡§
µÈÅÄ¡¡À¶ ¡ÊÀîºê°å²ÊÂç³Ø¡¡½Û´Ä´ïÆâ²Ê¡Ë
- 2¡¥The Role of Registries in Comparative Effectiveness Research
Ralph G. Brindis ¡ÊKaiser Permanente Medical Center and the American College of Cardiology, USA¡Ë
ºÂĹ¡§
ÅçËÜ¡¡ÏÂÌÀ ¡Ê»¥ËÚ°å²ÊÂç³Ø¡Ë
- 3¡¥Ablation of Atrial Fibrillation
Gerhard Hindricks ¡ÊUniversity of Leipzig, Heart Center, Germany¡Ë
ºÂĹ¡§
¾®Àî¡¡Áï ¡Ê¹ñºÝ°åÎÅÊ¡»ãÂç³Ø»°ÅÄɱ¡¡Ë
- 4¡¥Timing of Valve Replacement for Aortic Stenosis
Catherine M. Otto ¡ÊUniversity of Washington School of Medicine, USA¡Ë
ºÂĹ¡§
üâËÜ¡¡âÃ°ì ¡Ê»°°æµÇ°É±¡¡Ë
- 5¡¥Acute Heart Failure: Future Drug Development
Aldo P. Maggioni ¡ÊANMCO Research Center, Italy¡Ë
ºÂĹ¡§
ÅçÅÄ¡¡Ï¹¬ ¡Ê¼«¼£°å²ÊÂç³Ø¡¡½Û´Ä´ïÆâ²Ê¡Ë
- 6¡¥Innovative Devices in the Management of Stage D Heart Failure
John B. O'Connell ¡ÊHeart and Vascular Institute, St. Joseph's Hospital, USA¡Ë
ºÂĹ¡§
ËÙ¡¡¡¡ÀµÆó ¡ÊÂçºåÉÜΩÀ®¿ÍÉÂ¥»¥ó¥¿¡¼¡Ë
- 7¡¥Cardiac Deformation Imaging
Joseph Kisslo ¡ÊDuke University Medical Center, USA¡Ë
ºÂĹ¡§
Å¢¡¡ÃéÏ ¡Ê¼¯»ùÅçÂç³Ø¡¡½Û´Ä´ï¡¦¸ÆµÛ´ï¡¦Âå¼ÕÆâ²Ê³Ø¡Ë
- 8¡¥Cardiac Resynchronization Therapy: 2010
David L. Hayes ¡ÊMayo Clinic, USA¡Ë
ºÂĹ¡§
°æ¾å¡¡Çî ¡ÊÉÙ»³Âç³Ø¡¡Âè2 Æâ²Ê¡Ë